Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2023-12-20 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
关于使用超募资金及自有资金投资建设新项目的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Shenzhen Huitai Medical Devices Co., Ltd. regarding the use of over-raised funds and own funds to invest in a new project. It includes specifics about the fundraising, investment plans, project details, risk analysis, and approvals from the board, supervisory committee, independent directors, and the sponsor institution. The document references regulatory approvals, fundraising from an IPO, and compliance with listing rules. It is not a financial report like an annual or interim report, nor is it a simple announcement of a report publication. It is a capital/financing update related to the use of raised funds and investment in a new project, which fits the Capital/Financing Update (CAP) category.
2023-12-20 Chinese
关于修订《公司章程》及其附件的公告
Governance Information Classification · 95% confidence The document is a detailed announcement from Shenzhen Huitai Medical Device Co., Ltd. regarding amendments to the company's Articles of Association and related governance documents. It includes specific changes to company capital, board responsibilities, shareholder meeting rules, director qualifications, and other governance matters. The content is focused on corporate governance structure and internal rules rather than financial performance or audit results. There is no indication that this is a full annual report, audit report, earnings release, or other financial report. Instead, it is a governance-related announcement about changes to the company's bylaws and internal governance rules. Therefore, the document best fits the category of Governance Information (CGR). The document length and detail also support that it is the actual governance document, not just an announcement of a report publication.
2023-12-20 Chinese
中信证券股份有限公司关于深圳惠泰医疗器械股份有限公司部分募投项目延期的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding the delay in certain fundraising investment projects of Shenzhen Huitai Medical Device Co., Ltd. It references regulatory guidelines from the China Securities Regulatory Commission and the Shanghai Stock Exchange, discusses the use and management of funds raised from the company's initial public offering (IPO) on the STAR Market, and includes independent directors' and supervisory board opinions. The document is focused on the status and management of the use of raised funds, specifically addressing project delays and compliance with fundraising regulations. It is not a full annual or interim financial report, nor is it an earnings release or a call transcript. It is not a proxy statement, voting result, or a remuneration report. It is a regulatory compliance-related filing concerning fundraising project progress and fund usage, which fits best under Regulatory Filings (RNS). The document length is under 5,000 characters, but it contains substantive content rather than just an announcement of a report publication, so it is not an RPA. Therefore, the best classification is Regulatory Filings (RNS).
2023-12-20 Chinese
关于使用部分暂时闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Shenzhen Huitai Medical Devices Co., Ltd. regarding the use of temporarily idle raised funds for cash management. It details the board meeting resolutions, investment scope, risk analysis, and approvals by independent directors and the supervisory board. The document is about the company's plan and authorization to use idle raised funds for cash management, not a financial report or audit. It is a regulatory announcement related to capital management and fundraising usage, but it does not contain financial statements or detailed financial data. The document length is under 5,000 characters and is an announcement of a decision rather than a report itself. Therefore, it fits best under Capital/Financing Update (CAP).
2023-12-20 Chinese
关联交易管理制度
Governance Information Classification · 95% confidence The document is titled '关联交易管理制度' which translates to 'Related Party Transaction Management System' and contains detailed rules and procedures regarding related party transactions, including definitions, pricing, approval processes, and voting procedures. It references regulatory frameworks such as the Shanghai Stock Exchange rules and the China Securities Regulatory Commission. The content is a governance and compliance policy document rather than a financial report, earnings release, or announcement. It does not contain financial statements or results but rather internal rules and procedures for managing related party transactions. Therefore, it fits best under Governance Information (CGR). The document length (8334 characters) and detailed procedural content support this classification with high confidence.
2023-12-20 Chinese
公司章程
Governance Information Classification · 95% confidence The document is a detailed corporate charter or articles of association for Shenzhen Huitai Medical Devices Co., Ltd. It includes comprehensive sections on company organization, shareholder rights, board of directors, management, financial accounting, profit distribution, audit, and procedures for shareholder meetings. It references Chinese company law, securities law, and listing rules, indicating it is a formal governance document. The content is not a financial report, earnings release, or announcement but a governance framework document. Therefore, it fits best under Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2023-12-20 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.